Vaccine News and Research

Latest Vaccine News and Research

Green seaweed extract exhibits anti-SARS-CoV-2 activity in vitro

Researchers investigate the antiviral activities of SSPS extracted from green seaweed Ulva sp. to demonstrate the anti-SARS-CoV-2 activity of ulvans.

2 Dec 2021

‘Boost Day’ drive launches to mark one year since COVID-19 vaccine approval in the UK

The UK is marking one year since it became the first country in the world to approve Pfizer's COVID-19 vaccine with a "Boost Day" call.

2 Dec 2021

Researchers report antibody cocktails are promising candidate tools for controlling new SARS-CoV-2 variants

Researchers from Academia Sinica in Taiwan have been investigating new antibodies that could have strong effects against SARS-CoV-2 infection.

2 Dec 2021

Freeze-dried liposomes could be used in potential COVID-19 vaccines

Things that are freeze-dried: Astronaut food. Emergency rations. And, just maybe, some future COVID-19 vaccines.

1 Dec 2021

Pandemic may have impaired people's cognitive abilities and altered risk perception

The COVID-19 pandemic has tested our psychological limits. Some have been more affected than others by the stress of potential illness and the confusion of constantly changing health information and new restrictions.

1 Dec 2021

SARS-CoV-2 infection risks increase with time in fully vaccinated adults

A recent study describes the association between time elapsed since the second dose of the Pfizer-BioNTech BNT162b2 vaccine and risk of COVID-19.

1 Dec 2021

Single-dose HPV vaccine could be effective for preventing cervical cancer

A single dose of human papillomavirus (HPV) vaccine could be effective for preventing cervical cancer, raising hopes of fighting the disease in Sub-Saharan Africa, a conference has heard.

1 Dec 2021

Fourth shot of Moderna COVID vaccine improves Delta variant neutralization in kidney transplant patients

New research suggests that a fourth dose of the mRNA-1273 vaccine in kidney transplant recipients improves Delta variant serum neutralization.

1 Dec 2021

Novel approach to estimate transmission advantage of SARS-CoV-2 variants in real-time

A new study retrospectively estimates the effective transmission advantage of the Alpha variant as compared to other non-VOC lineages.

1 Dec 2021

Longer interval between COVID-19 mRNA vaccine doses leads to stronger immune response

The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada through its COVID-19 Immunity Task Force.

1 Dec 2021

Safety and immunogenicity of different COVID-19 booster vaccines

New study findings suggest that booster vaccination with an mRNA-based vaccine has the highest immunogenicity against the COVID-19 Delta variant.

1 Dec 2021

Structure function analysis of potent antibodies against Beta SARS-CoV-2 variant

A team of researchers from UK and US institutions created a large panel of mAbs derived from memory B cells of convalescent Beta subjects to better understand the antigenic landscape of Beta.

1 Dec 2021

Plant-derived virus-like particle vaccines against SARS-CoV-2

In a review published in Biotechnology Letters, the authors discuss plant-derived VLP-based vaccines.

1 Dec 2021

Impact of SARS-CoV-2 on oral health

New research examined SARS-CoV-2 and its impact on oral health and suggests that survival against the infection may be partially dependent on such factors.

1 Dec 2021

COVID-19 vaccination status based infection likelihood in New Zealand

A new study has determined the possible number of infections caused by an unvaccinated versus vaccinated individual.

1 Dec 2021

Comparison of peptides from human cardiac proteins and SARS-CoV-2 proteins

A new study investigated whether linear peptides contained in proteins (primarily expressed in the heart) also occur in the SARS-CoV-2 proteome.

1 Dec 2021

Unvaccinated white evangelicals seem to be resistant to persuasive pro-vaccine messages

White evangelical Christians have resisted getting vaccinated against COVID-19 at higher rates than other religious groups in the United States. A new study by Yale researchers provides evidence that persuading these vaccine holdouts to get their shots has only gotten more difficult.

30 Nov 2021

Vaccine News and Research

Latest Vaccine News and Research

Green seaweed extract exhibits anti-SARS-CoV-2 activity in vitro

‘Boost Day’ drive launches to mark one year since COVID-19 vaccine approval in the UK

Researchers report antibody cocktails are promising candidate tools for controlling new SARS-CoV-2 variants

Freeze-dried liposomes could be used in potential COVID-19 vaccines

Pandemic may have impaired people's cognitive abilities and altered risk perception

SARS-CoV-2 infection risks increase with time in fully vaccinated adults

Single-dose HPV vaccine could be effective for preventing cervical cancer

Fourth shot of Moderna COVID vaccine improves Delta variant neutralization in kidney transplant patients

Novel approach to estimate transmission advantage of SARS-CoV-2 variants in real-time

Longer interval between COVID-19 mRNA vaccine doses leads to stronger immune response

Safety and immunogenicity of different COVID-19 booster vaccines

Structure function analysis of potent antibodies against Beta SARS-CoV-2 variant

Plant-derived virus-like particle vaccines against SARS-CoV-2

Impact of SARS-CoV-2 on oral health

COVID-19 vaccination status based infection likelihood in New Zealand

Comparison of peptides from human cardiac proteins and SARS-CoV-2 proteins

Unvaccinated white evangelicals seem to be resistant to persuasive pro-vaccine messages

Nanoengineers develop a new approach to effectively deliver mRNA into cells

Study compares NAbs from natural SARS-CoV-2 infection vs. vaccine induced against symptomatic infection

Study identifies two genes that play key role in protecting ovarian cancer from the immune system

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in